Suicidality and substance misuse in first-admitted subjects with psychotic disorder

Acta Psychiatrica Scandinavica

Volumn 100, Issue 5, 1999, Pages 389-395

  Verdoux, H ^a,b,d   Liraud, F ^a,b   Gonzales, B ^b   Assens, F ^b   Abalan, F ^b   Van Os, J ^c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CENTRE HOSPITALIER CHARLES PERRENS   (France)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d Centre Carreire   (France)

Author keywords

First episode; Psychosis; Substance use; Suicide attempt

Indexed keywords

ALCOHOL; ANXIOLYTIC AGENT; CANNABIS; COCAINE; OPIATE; PSYCHEDELIC AGENT; SEDATIVE AGENT;

ADOLESCENT; ADULT; ALCOHOL ABUSE; ARTICLE; DRUG ABUSE; FEMALE; HIGH RISK PATIENT; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; SUBSTANCE ABUSE; SUICIDE ATTEMPT;

EID: 0032717974     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1999.tb10883.x     Document Type: Article

References (31)

1. 1. Brown S. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry 1997;171:502-508.
2. 2. Mortensen PB, Juel K. Mortality and causes of death in first-admitted schizophrenic patients. Br J Psychiatry 1993;163:183-189.
3. 3. Rosau CD, Mortensen PB. Risk factors for suicide in patients with schizophrenia: nested case-control study. Br J Psychiatry 1997;171:355-359.
4. 4. Caldwell CB, Gottesman II. Schizophrenics kill themselves too. Schizophr Bull 1990;16:571-586.
5. 5. Hawton K, Fagg J, Platt S, Hawkins M. Factors associated with suicide after parasuicide in young people. Br Med J 1993;306:1641-1644.
6. 6. Shaffer D, Gould MS, Fisher P. Psychiatric diagnosis in child and adolescent suicide. Arch Gen Psychiatry 1996;53:339-348.
7. 7. Neeleman J, Farrell M. Suicide and substance misuse. Br J Psychiatry 1997;171:303-304.
8. 8. Hambrecht M, Häfner H. Substance abuse and the onset of schizophrenia. Biol Psychiatry 1996;40:1155-1163.
9. 9. Roy A. Suicide in schizophrenia. In: Roy A, ed. Suicide. Baltimore, MD: Williams & Wilkins, 1986:97-112.
10. 10. Philippe A, Casadebaig J. Mortality among schizophrenic patients. Communication at the ninth European Symposium of the Association of European Psychiatrists Section Committee on Psychiatric Epidemiology and Social Psychiatry, April 1988, Beaune, France.
11. 11. Kovasznay B, Bromet E, Schwartz JE, Ram R, Lavelle J, Brandon L. Substance abuse and the onset of psychotic illness. Hosp Commun Health 1993;44:567-571.
12. 12. Cohen S, Lavelle J, Rich CL, Bromet E. Rates and correlates of suicide attempts in first-admission psychotic patients. Acta Psychiatr Scand 1994;90:167-171.
13. 13. Ananth J, Vandewater S, Kamal M, Brodsky A, Gamal R, Miller M. Missed diagnosis of substance abuse in psychiatric patients. Hosp Commun Psychiatry 1989; 40:297-299.
14. 14. Shaner A, Khalsa ME, Roberts L, Wilkins J, Anglin D, Hsieh SC. Unrecognized cocaine use among schizophrenic patients. Am J Psychiatry 1993;150:758-762.
15. 15. Verdoux H, Bergey C, Assens F et al. Prediction of duration of psychosis before first admission. Eur Psychiatry 1998;13:346-352.
16. 16. Lecrubier Y, Seehan DV, Weiller E et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 1997;2: 224-231.
17. 17. Guy W. Assessment manual for psychopharmacology. National Institute of Mental Health, Early Clinical Drug Evaluation Unit, 1976.
18. 18. Kay SR, Fizbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.
19. 19. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, revised 3rd edn (DSM-III-R). Washington, DC: American Psychiatric Association, 1987.
20. 20. STATA Corporation. STATA statistical software: Release 4.0. College Station, TX: STATA Corporation, 1995.
21. 21. Clayton D, Hills M. Choice and interpretation of models. In: Statistical models in epidemiology. Oxford: Oxford University Press, 1993:271-281.
22. 22. Hennekens CH, Buring JE. Measures of disease frequency. In: Epidemiology in medicine. Boston, MA: Little, Brown and Co., 1987:54-98.
23. 23. Ram R, Bromet EJ, Eaton WW, Pato C, Schwartz JE. The natural course of schizophrenia: a review of first-admission studies. Schizophr Bull 1992;18:185-207.
24. 24. Poole R, Brabbins C. Drug-induced psychosis. Br J Psychiatry 1996;168:135-138.
25. 25. Addington J, Addington D. Effect of substance misuse in early psychosis. Br J Psychiatry 1998;172(Suppl. 33): 134-136.
26. 26. Ahrens B, Linden M. Is there is a suicidality syndrome independent of specific major psychiatric disorder? Acta Psychiatr Scand 1996;94:79-86.
27. 27. Verdoux H, Mury M, Besançon G, Bourgeois M. Etude comparative des conduites toxicomaniaques dans les troubles bipolaires, schizophréniques, et schizoaffectifs. Encephale 1996;22:95-101.
28. 28. Nordström P, Schalling D, Åsberg M. Temperamental vulnerability in attempted suicide. Acta Psychiatr Scand 1995;92:155-160.
29. 29. Chastang F, Rioux P, Dupont I, Baranger E, Kovess V, Zarifian E. Risk factors associated with suicide attempt in French young people. Acta Psychiatr Scand 1998;98: 474-479.
30. 30. Carlson GA, Rich CL, Grayson P, Fowler RC. Secular trends in psychiatric diagnoses of suicide victims. J Affect Disord 1991;21:127-132.
31. 31. Munk-Jørgensen P, Mortensen PB. Incidence and other aspects of the epidemiology of schizophrenia in Denmark, 1971-87. Br J Psychiatry 1992;161:489-495.